Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
Journal of Managed Care Pharmacy, 08/07/09
Sanoski CA et al. – The growing cost of AF in the United States and the problems associated with drug therapies used to manage AF represent both challenges and opportunities for pharmacists in managed care. Managed care pharmacists can play an instrumental role in improving the cost–effectiveness of and outcomes from drug therapy in patients with AF through a variety of strategies.
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/03/09
Societal cost of rheumatoid arthritis patients in the US
Current Medical Research and Opinion, 11/13/09
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation
Current Medical Research and Opinion, 11/13/09
Sponsor
Article Search
Sponsor


See Latest Articles


